American Healthcare REIT, Inc. (AHR) Stock Forecast & Price Target
American Healthcare REIT, Inc. · NYSE
$54.63-0.09 (-0.16%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 12 firms covering American Healthcare REIT, Inc, 12 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets span $50.00 to $70.00, a moderate spread. The average target of $61.75 sits 13% above the current $54.63. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 11 to 12 over recent months. On the fundamentals, the Street sees revenue growth near 20% this year and 10% next, consensus EPS building from about $0.20 next quarter toward $0.99 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS12 ratings
Strong Buy
Strong Buy00%
Buy12100%
Hold00%
Sell00%
Strong Sell00%
Based on 12 analysts giving stock ratings to American Healthcare REIT, Inc.
As of Sep, 12 of 12 firms rate AHR a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
AHR EPS & revenue forecast
EPS · NEXT QUARTER
$0.20
Range $0.20 – $0.20 · 1 analysts · +39% YoY
Next period, 1 analysts expect American Healthcare REIT, Inc. to earn $0.20 a share (range $0.20 – $0.20), versus $0.14 a year earlier. Full-year consensus is $0.60, growing to $0.99 the year after.
REVENUE · NEXT QUARTER
$761.1M
Range $701.1M – $846.4M · 1 analysts · +20% YoY
Revenue is expected to reach $761.1M (range $701.1M – $846.4M), +20.0% year-over-year. Full-year consensus is $2.8B, rising to $3.2B next year.
Top analysts covering American Healthcare REIT, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on AHR.
#1
Nicholas Yulico
Scotiabank · Rank #68
Buy
$62.00+13.5% to target
Overall win rate
51%
+ Follow
#2
Michael Lewis
Truist Securities · Rank #187
Buy
$61.00+11.7% to target
Overall win rate
42%
+ Follow
#3
Aaron Hecht
JMP Securities · Rank #237
Buy
$65.00+19.0% to target
Overall win rate
46%
+ Follow
#4
AW
Austin Wurschmidt
KeyBanc
Buy
$68.00+24.5% to target
Coverage
—
+ Follow
#5
Michael Carroll
RBC Capital
Buy
$61.00+11.7% to target
Coverage
—
+ Follow
AHR stock forecast FAQ
What is AHR's average 12-month price target?+
The 12 analysts with a live target average $61.75 for American Healthcare REIT, Inc. over the next 12 months, ranging from a $70.00 high to a $50.00 low.
Is AHR stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 12 analyst ratings, 12 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for AHR?+
The Street-high target is $70.00 (Compass Point), and the Street-low is $50.00 (JMP Securities). The average of all 12 active targets is $61.75.
How many Wall Street analysts cover AHR?+
12 analysts have an active rating on American Healthcare REIT, Inc., and 12 firms carry a live 12-month price target.
Who is the most accurate analyst covering AHR?+
Among analysts who currently cover AHR, Nicholas Yulico of Scotiabank has the strongest overall Quantellect track record (Rank #68). Their current call is Buy with a $62.00 target.
What is American Healthcare REIT, Inc.'s projected EPS for next quarter?+
The consensus estimate is $0.20 per share (range $0.20 – $0.20) across 1 analysts. Full-year EPS is projected at $0.60, rising to $0.99 the following year.
How much revenue is American Healthcare REIT, Inc. expected to report next quarter?+
Consensus revenue is $761.1M (range $701.1M – $846.4M). Full-year revenue is projected at $2.8B, growing to $3.2B next year.
Have analysts been upgrading or downgrading AHR lately?+
As of Sep, 12 of 12 firms rate AHR a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AHR calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
